JPRN-UMIN000030551已完成未知
Phase I study of nab-paclitaxel and gemcitabine chemoradiotherapy for borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinoma - Phase I study of nab-paclitaxel and gemcitabine CRT for BR and UR-LA PDAC
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with allergy for nab-paclitaxel and gemcitabine 2) Patients with severe infection 3) Patients who are considered to be inappropriate for this study
研究者
相似试验
已完成
不适用
Phase I/II study of gemcitabine and nab-paclitaxel with radiation therapy in patients with pancreatic cancer.pancreatic cancerJPRN-UMIN000017751Department of Surgery, Keio University School of Medicine30
进行中（未招募）
1 期
Study of Nab-paclitaxel and Gemcitabine in Elderly Patients with Pancreatic CancerMetastatic pancreatic cancerMedDRA version: 17.1 Level: PT Classification code 10033610 Term: Pancreatic carcinoma metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-003596-27-ESAsociación de Oncología Médica del Hospital de Cruces (ASONMEC)80
已完成
不适用
A phase II study of gemcitabine and nab-paclitaxel followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancerJPRN-UMIN000026525Chiba Cancer Center30
已完成
2 期
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
已完成
1 期
Phase 1 trial of Nab-paclitaxel and Gemcitabine for metastatic breast cancerBreast cancerJPRN-UMIN000010125Tokyo-West Tokushukai Hospital6